Variability of EMG patterns: A potential neurophysiological marker of Parkinson's disease?

Clinical Neurophysiology

Volumn 120, Issue 2, 2009, Pages 390-397

  Robichaud, Julie A ^a   Pfann, Kerstin D ^a   Leurgans, Sue ^b   Vaillancourt, David E ^a,c   Comella, Cynthia L ^b   Corcos, Daniel M ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c University of Illinois at Chicago   (United States)

Author keywords

Disease progression; Disease severity; Electromyographic (EMG) activity; Isotonic movements; Parkinson's disease

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; SELEGILINE; TERAZOSIN; TRIHEXYPHENIDYL; UBIDECARENONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROL GROUP; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ELBOW FLEXION; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; MOTOR ACTIVITY; NEUROPHYSIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; ANALYSIS OF VARIANCE; ARM; BIOMECHANICS; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PARKINSON DISEASE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 59349097192     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2008.10.015     Document Type: Article

References (34)

1. Antonini A., Moresco R.M., Gobbo C., De Notaris R., Panzacchi A., Barone P., et al. The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. Neurol Sci 22 (2001) 47-48
2. Benamer T.S., Patterson J., Grosset D.G., Booij J., de Bruin K., van Royen E., et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15 (2000) 503-510
3. Berardelli A., Dick J.P., Rothwell J.C., Day B.L., and Marsden C.D. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 49 (1986) 1273-1279
4. Buchman A.S., Leurgans S., Gottlieb G.L., Chen C.H., Almeida G.L., and Corcos D.M. Effect of age and gender in the control of elbow flexion movements. J Mot Behav 32 (2000) 391-399
5. Camicioli R., Grossmann S.J., Spencer P.S., Hudnell K., and Anger W.K. Discriminating mild parkinsonism: methods for epidemiological research. Mov Disord 16 (2001) 33-40
6. Corcos D.M., Chen C.M., Quinn N.P., McAuley J., and Rothwell J.C. Strength in Parkinson's disease: relationship to rate of force generation and clinical status. Ann Neurol 39 (1996) 79-88
7. Corcos D.M., Gottlieb G.L., and Agarwal G.C. Organizing principles for single-joint movements. II. A speed-sensitive strategy. J Neurophysiol 62 (1989) 358-368
8. Corcos D.M., Gottlieb G.L., Latash M.L., Almeida G.L., and Agarwal G.C. Electromechanical delay: an experimental artifact. J Electromyogr Kinesiol 2 (1992) 59-68
9. DeKosky S.T., and Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 302 (2003) 830-834
10. Fahn S., Elton R.L., and Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S., Marsden C.D., Calne D.B., and Goldstein M. (Eds). Recent developments in Parkinson's disease. II (1987), MacMillan Health Care Information, New Jersey 153-163
11. Farley B.G., Sherman S., and Koshland G.F. Shoulder muscle activity in Parkinson's disease during multijoint arm movements across a range of speeds. Exp Brain Res 154 (2004) 160-175
12. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
13. Hallett M., and Khoshbin S. A physiological mechanism of bradykinesia. Brain 103 (1980) 301-314
14. Hallett M., Shahani B.T., and Young R.R. Analysis of stereotyped voluntary movements at the elbow in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 40 (1977) 1129-1135
15. Hu M.T., White S.J., Herlihy A.H., Chaudhuri K.R., Hajnal J.V., and Brooks D.J. A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 56 (2001) 1195-1200
16. Huang C., Tang C., Feigin A., Lesser M., Ma Y., Pourfar M., et al. Changes in network activity with the progression of Parkinson's disease. Brain 30 (2007) 1834-1846
17. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases [see comments]. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
18. Hughes A.J., Daniel S.E., and Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57 (2001) 1497-1499
19. Ichise M., Kim Y.J., Ballinger J.R., Vines D., Erami S.S., Tanaka F., et al. SPECT imaging of pre- and postsynaptic dopaminergic alterations in l-dopa-untreated PD. Neurology 52 (1999) 1206-1214
20. Michell A.W., Lewis S.J., Foltynie T., and Barker R.A. Biomarkers and Parkinson's disease. Brain 127 (2004) 1693-1705
21. Montgomery Jr. E.B., Koller W.C., LaMantia T.J., Newman M.C., Swanson-Hyland E., Kaszniak A.W., et al. Early detection of probable idiopathic Parkinson's disease. I. Development of a diagnostic test battery. Mov Disord 15 (2000) 467-473
22. Montgomery Jr. E.B., Lyons K., and Koller W.C. Early detection of probable idiopathic Parkinson's disease. II. A prospective application of a diagnostic test battery. Mov Disord 15 (2000) 474-478
23. Morrish P.K., Rakshi J.S., Bailey D.L., Sawle G.V., and Brooks D.J. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64 (1998) 314-319
24. Morrish P.K., Sawle G.V., and Brooks D.J. Clinical and [18F]dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry 59 (1995) 597-600
25. Pepe M.S. The statistical evaluation of medical tests for classification and prediction (2003), Oxford University Press, Oxford
26. Pfann K.D., Buchman A.S., Comella C.L., and Corcos D.M. Control of movement distance in Parkinson's disease. Mov Disord 16 (2001) 1048-1065
27. Pfann K.D., Hoffman D.S., Gottlieb G.L., Strick P.L., and Corcos D.M. Common principles underlying the control of rapid, single degree-of-freedom movements at different joints. Exp Brain Res 118 (1998) 35-51
28. Rissanen S., Kankaanpaa M., Tarvainen M.P., Nuutinen J., Tarkka I.M., Airaksinen O., et al. Analysis of surface EMG signal morphology in Parkinson's disease. Physiol Meas 28 (2007) 1507-1521
29. Robichaud J.A., Pfann K.D., Comella C.L., Brandabur M., and Corcos D.M. Greater impairment of extension movements as compared to flexion movements in Parkinson's disease. Exp Brain Res 156 (2004) 240-254
30. Robichaud J.A., Pfann K.D., Comella C.L., and Corcos D.M. Effect of medication on EMG patterns in individuals with Parkinson's disease. Mov Disord 17 (2002) 950-960
31. Robichaud J.A., Pfann K.D., Vaillancourt D.E., Comella C.L., and Corcos D.M. Force control and disease severity in Parkinson's disease. Mov Disord 20 (2005) 441-450
32. Tissingh G., Berendse H.W., Bergmans P., DeWaard R., Drukarch B., Stoof J.C., et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 16 (2001) 41-46
33. Vaillancourt D.E., Prodoehl J., Metman L.V., Bakay R.A., and Corcos D.M. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease. Brain 127 (2004) 1-14
34. Volkow N.D., Rosen B., and Farde L. Imaging the living human brain: magnetic resonance imaging and positron emission tomography. Proc Natl Acad Sci USA 94 (1997) 2787-2788